Volume 47(2); 2024 Apr
Article
Sahan Chandrasekara, Peter Wark
Aust Prescr. 2024 Apr; 47(2): 36–42. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.015
- PMCID:
- PMC11081739
Letters to the Editor
Aust Prescr. 2024 Apr; 47(2): 43–45. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.017
- PMCID:
- PMC11081740
Aust Prescr. 2024 Apr; 47(2): 46–47. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.009
- PMCID:
- PMC11081738
Articles
Erica Y Tong, Gary Yip
Aust Prescr. 2024 Apr; 47(2): 48–51. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.011
- PMCID:
- PMC11081735
Daniel Hynes, Darren Mansfield
Aust Prescr. 2024 Apr; 47(2): 52–56. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.010
- PMCID:
- PMC11081737
Garry Jennings, Natalie Raffoul, Mark Nelson, Expert Steering Group for the 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk
Aust Prescr. 2024 Apr; 47(2): 57–63. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.014
- PMCID:
- PMC11081742
New Drugs
Aust Prescr. 2024 Apr; 47(2): 64–65. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.016
- PMCID:
- PMC11081734
Aust Prescr. 2024 Apr; 47(2): 66–67. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.013
- PMCID:
- PMC11081741
Aust Prescr. 2024 Apr; 47(2): 68–69. Published online 2024 Apr 23. doi: 10.18773/austprescr.2024.013
- PMCID:
- PMC11081736
Articles from Australian Prescriber are provided here courtesy of Therapeutic Guidelines Ltd